Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Dasatinib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679364B reveals a cleaner route for Dasatinib intermediates. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109503511B reveals a novel 2-step synthesis for dasatinib intermediates using PEG 400, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.